Abstract
It has been suggested that cancer represents an alteration in DNA, heritable by progeny cells, that leads to abnormally regulated expression of normal cellular genes; DNA alterations such as mutations1,2, rearrangements3–5 and changes in methylation6–8 have been proposed to have such a role. Because of increasing evidence that DNA methylation is important in gene expression (for review see refs 7, 9–11), several investigators have studied DNA methylation in animal tumours, transformed cells and leukaemia cells in culture8,12–30. The results of these studies have varied; depending on the techniques and systems used, an increase12–19, decrease20–24, or no change25–29 in the degree of methylation has been reported. To our knowledge, however, primary human tumour tissues have not been used in such studies. We have now examined DNA methylation in human cancer with three considerations in mind: (1) the methylation pattern of specific genes, rather than total levels of methylation, was determined; (2) human cancers and adjacent analogous normal tissues, unconditioned by culture media, were analysed; and (3) the cancers were taken from patients who had received neither radiation nor chemotherapy. In four of five patients studied, representing two histological types of cancer, substantial hypomethylation was found in genes of cancer cells compared with their normal counterparts. This hypomethylation was progressive in a metastasis from one of the patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McCann, J. & Ames, B. N. Proc. natn. Acad. Sci. U.S.A. 73, 950–954 (1976).
Meselson, M. & Russel, K. in Origins of Human Cancer Vol. 4 (eds Hiatt, H. H., Watson, J. D. & Winsten, J. A.) 1473–1481 (Cold Spring Harbor, New York, 1977).
Sager, R. Nature 282, 447–448 (1979).
Cairns, J. Nature 289, 353–357 (1981).
Humphreys, P. Nature 293, 146–148 (1981).
Holliday, R. Br. J. Cancer 40, 513–521 (1979).
Ehrich, M. & Wang, R. Y.-H. Science 212, 1350–1357 (1981).
Sager, R. in Tumor Cell Heterogeneity: Origins and Implications (eds Owens, A. H., Coffey, D. S. & Baylin, S. B.) 411–423 (Academic, New York, 1982).
Razin, A. & Riggs, A. D. Science 210, 604–610 (1980).
Doerfler, W. J. gen. Virol. 57, 1–20 (1981).
Felsenfeld, G. & McGhee, J. Nature 296, 602–603 (1981).
Silber, R. et al. Biochim. biophys. Acta 123, 638–640 (1966).
Desai, L. S., Wulff, U. C. & Foley, G. E. Expl Cell Res. 65, 260–263 (1971).
Shirakawa, S. & Saunders, G. F. Proc. Soc. exp. Biol. Med. 138, 369–372 (1971).
Rubery, E. D. & Newton, A. A. Biochim. biophys. Acta 324, 24–36 (1973).
Gunthert, U., Schweiger, M., Stupp, M. & Doerfler, W. Proc. natn. Acad. Sci. U.S.A. 73, 3923–3927 (1976).
Fedorov, N. A., Kuzmichev, V. A., Kritsky, G. A. & Vinogradova, Yu. E. Biokhimiya 42, 1020–1023 (1977).
Nakhasi, H. L., Lynch, K. R., Dolan, K. P., Unterman, R. D. & Feigelson, P. Proc. natn. Acad. Sci. U.S.A. 78, 834–837 (1981).
Nass, M. M. K. J. molec. Biol. 80, 155–175 (1973).
Burtseva, N. N., Axizov, Yu. M., Itkin, B. Z. & Vanyushin, B. F. Biokhimiya 42, 1690–1696 (1977).
Lapeyre, J.-N. & Becker, F.F. Biochem. biophys. Res. Commun. 87, 698–705 (1979).
Cohen, J. C. Cell 19, 653–662 (1980).
Reilly, J. G., Thomas, C. A. Jr & Sen, A. Biochim. biophys. Acta 697, 53–59 (1982).
Nakhasi, H. L. et al. J. biol. Chem. 257, 2726–2729 (1982).
Gantt, R., de Oca, F. M. & Evans, V. J. In Vitro 8, 288–294 (1973).
Singer, J., Stellwagen, R. H., Roberts-Ems, J. & Riggs, A. D. J. biol. Chem. 252, 5509–5513, (1977).
Browne, M. J. & Burdon, R. H. Nucleic Acids Res. 4, 1025–1037 (1977).
Diala, E. S. & Hoffman, R. M. Biochem. biophys. Res. Commun. 104, 1489–1494 (1982).
McKeon, C., Ohkubo, H., Pastan, I. & de Crombrugghe, B. Cell 29, 203–210 (1982).
Kuhlmann, I. & Doerfler, W. Virology 118, 169–180 (1982).
Mann, M. B. & Smith, H. O. Nucleic Acids Res. 4, 4211–4221 (1977).
Bird, A. P. & Southern, E. M. J. molec. Biol. 118, 27–47 (1978).
Van der Ploeg, L. H. T. & Flavell, R. A. Cell 19, 947–958 (1980).
Hall, R. H. The Modified Nucleosides in Nucleic Acids, 281–294 (Columbia, New York, 1971).
Bird, A. P. J. molec. Biol. 118, 49–60 (1978).
Pollack, Y., Stein, R., Razin, A. & Cedar, H. Proc. natn. Acad. Sci. U.S.A. 77, 6463–6467 (1980).
Wigler, M., Levy, D. & Perucho, M. Cell 24, 33–40 (1981).
Harland, R. M. Proc. natn. Acad. Sci. U.S.A. 79, 2323–2327 (1982).
Southern, E. M. J. molec. Biol. 98, 503–517 (1975).
Wahl, G. M., Stern, M. & Stark, G. R. Proc. natn. Acad. Sci. U.S.A. 76, 3683–3687 (1979).
Martial, J. A., Hallewell, R. A., Baxter, J. D. & Goodman, H. M. Science 205, 602–607 (1979).
Wilson, J. T. et al. Nucleic Acids Res. 5, 563–581 (1978).
Sugarbaker, P. H., Macdonald, J. S. & Gunderson, L. L. in Cancer: Principles and Practice of Oncology (eds De Vita, V. T. Jr, Hellman, S.&Rosenberg, S. A.) 643–723 (Lippincott, Philadelphia, 1982).
Moore, D. D., Conkling, M. A. & Goodman, H. M. Cell 29, 285–286 (1982).
Waalwijk, C. & Flavell, R. A. Nucleic Acids Res. 5, 3231–3236 (1978).
Sneider, T. W. Nucleic Acids Res. 8, 3829–3840 (1980).
Van der Ploeg, L. H. T., Groffen, J. & Flavell, R. A. Nucleic Acids Res. 8, 4563–4574 (1980).
Stein, R., Gruenbaum, Y., Pollack, Y., Razin, A. & Cedar, H. Proc. natn. Acad. Sci. U.S.A. 79, 61–65 (1982).
Owens, A. H., Coffey, D. S. & Baylin, S. B. Tumor Cell Heterogeneity: Origins and Implications (Academic, New York, 1982).
McKusick, V. A. Cytogenet. Cell Genet. 32, 1–343 (1982).
Gross-Bellard, M., Oudet, P. & Chambon, P. Eur. J. Biochem. 36, 32–38 (1973).
Brunk, C. F., Jones, K. C. & James, T. W. Analyt. Biochem. 92, 497–500 (1979).
Colman, A., Byers, M.J., Primose, S.B. & Lyons, A. Eur. J. Biochem. 91, 303–310 (1978).
Birnboim, H. C. & Dolly, J. Nucleic Acids Res. 7, 1513–1523 (1979).
Feinberg, A. P. & Vogelstein, B. Analyt. Biochem. (submitted).
Peden, K., Mounts, P. & Hayward, G. S. Cell 31, 71–80 (1982).
Laskey, R. A. & Mills, A. D. FEBS Lett. 82, 314–316 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Feinberg, A., Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89–92 (1983). https://doi.org/10.1038/301089a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/301089a0